Literature DB >> 12482075

Neural substrates of spoken language rehabilitation in an aphasic patient: an fMRI study.

A Léger1, J F Démonet, S Ruff, B Aithamon, B Touyeras, M Puel, K Boulanouar, D Cardebat.   

Abstract

Little is known about the neural counterparts of speech therapy in aphasic patients. An fMRI experiment was performed before and after a specific and intensive speech output therapy in RC, a patient with long-lasting speech output deficit following a left-sided ischemic lesion. Overt picture naming and picture/word rhyming were used as activation tasks in RC and 6 control subjects. The naming task concerned the output lexicon deficit to be rehabilitated while rhyming referred to preserved levels of processing and was used to control for repetition effect. The speech therapy program improved naming performance. By comparison to the pattern observed before therapy, the naming task after therapy induced a pattern of activation close to that observed in control subjects, involving left-sided language areas surrounding the lesion. Speech therapy effect was associated with activations in Broca's area and the left supra-marginal gyrus, which might reflect a therapy-induced phonological compensatory strategy for naming.

Entities:  

Mesh:

Year:  2002        PMID: 12482075     DOI: 10.1006/nimg.2002.1238

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  43 in total

Review 1.  Research with rTMS in the treatment of aphasia.

Authors:  Margaret A Naeser; Paula I Martin; Ethan Treglia; Michael Ho; Elina Kaplan; Shahid Bashir; Roy Hamilton; H Branch Coslett; Alvaro Pascual-Leone
Journal:  Restor Neurol Neurosci       Date:  2010       Impact factor: 2.406

2.  Improved language in a chronic nonfluent aphasia patient after treatment with CPAP and TMS.

Authors:  Margaret A Naeser; Paula I Martin; Kristine Lundgren; Reva Klein; Jerome Kaplan; Ethan Treglia; Michael Ho; Marjorie Nicholas; Miguel Alonso; Alvaro Pascual-Leone
Journal:  Cogn Behav Neurol       Date:  2010-03       Impact factor: 1.600

3.  Intrasubject reproducibility of functional MR imaging activation in language tasks.

Authors:  G S Harrington; M H Buonocore; S Tomaszewski Farias
Journal:  AJNR Am J Neuroradiol       Date:  2006-04       Impact factor: 3.825

Review 4.  Functional neuroimaging studies of cognitive recovery after acquired brain damage in adults.

Authors:  Juan M Muñoz-Cespedes; Marcos Rios-Lago; Nuria Paul; Fernando Maestu
Journal:  Neuropsychol Rev       Date:  2005-12       Impact factor: 7.444

5.  Strategies for longitudinal neuroimaging studies of overt language production.

Authors:  Jed A Meltzer; Whitney A Postman-Caucheteux; Joseph J McArdle; Allen R Braun
Journal:  Neuroimage       Date:  2009-05-07       Impact factor: 6.556

6.  Using Vision to Study Poststroke Recovery and Test Hypotheses About Neurorehabilitation.

Authors:  Ania Busza; Colleen L Schneider; Zoë R Williams; Bradford Z Mahon; Bogachan Sahin
Journal:  Neurorehabil Neural Repair       Date:  2019-02       Impact factor: 3.919

Review 7.  Neuroimaging in aphasia treatment research: issues of experimental design for relating cognitive to neural changes.

Authors:  Brenda Rapp; David Caplan; Susan Edwards; Evy Visch-Brink; Cynthia K Thompson
Journal:  Neuroimage       Date:  2012-09-10       Impact factor: 6.556

8.  Neuroimaging and recovery of language in aphasia.

Authors:  Cynthia K Thompson; Dirk-Bart den Ouden
Journal:  Curr Neurol Neurosci Rep       Date:  2008-11       Impact factor: 5.081

9.  Behavioral and neurophysiologic response to therapy for chronic aphasia.

Authors:  Joshua I Breier; Jenifer Juranek; Lynn M Maher; Stephanie Schmadeke; Disheng Men; Andrew C Papanicolaou
Journal:  Arch Phys Med Rehabil       Date:  2009-12       Impact factor: 3.966

Review 10.  Neuroimaging in aphasia treatment research: standards for establishing the effects of treatment.

Authors:  Swathi Kiran; Ana Ansaldo; Roelien Bastiaanse; Leora R Cherney; David Howard; Yasmeen Faroqi-Shah; Marcus Meinzer; Cynthia K Thompson
Journal:  Neuroimage       Date:  2012-10-09       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.